Infliximab

• CAT Number: M035197
• CAS Number: 170277-31-3
• Molecular Formula: C7H7N3O2
• Purity: ≥95%
• Target: Anti-infection
• Storage: Desiccate at +4C

Infliximab (Cat No.: M035197) is a monoclonal antibody that targets and inhibits tumor necrosis factor-alpha (TNF-α), a key cytokine involved in inflammatory responses. By blocking TNF-α, infliximab helps reduce inflammation and immune system activity, making it effective in treating autoimmune diseases like rheumatoid arthritis, Crohn’s disease, ulcerative colitis, and psoriasis. It is administered through intravenous infusion and has been shown to improve symptoms and prevent disease progression in these conditions. Its use, however, may require monitoring for potential side effects like infections.